Clinical Trials Directory

Trials / Completed

CompletedNCT01724515

PGC-1 and Mitochondrial Dysfunction in Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is determine if you have too much fat in your body that it will decrease the conversion of food energy into energy that your body can use.

Detailed description

The investigators' prior research has focused on defining the changes in expression of nuclear encoded mitochondrial genes that predict changes in insulin sensitivity in skeletal muscle, with the goal of defining the molecular mechanisms underlying the connection between mitochondrial dysfunction and insulin resistance in skeletal muscle. The purpose of this study is to determine whether experimental lipid oversupply decreases mitochondrial respiratory function. We will use mitochondrial respiration studies in vitro and mass spectrometry and proteomics analysis to test the hypothesis that experimental lipid oversupply: 1. Decreases mitochondrial respiration in response to lipid fuels. 2. Reduces abundance of mitochondrial proteins. 3. Alters phosphorylation of proteins in the electron transport chain. Three groups of subjects will be studied: lean, healthy control subjects (n=12), obese non-diabetic subjects (n=12) and patients with type 2 Diabetes Mellitus (n=12) for a total of 36 subjects. Twenty subjects have completed the study at Arizona State University; the remaining 16 subjects will be accrued at the Mayo Clinic in Arizona. Subjects will come to the Mayo Clinic 2 times. On study Day 1 subjects will be screened with a medical history and physical exam, and a 75 g oral glucose tolerance test, measure body fat percentage, and an electrocardiogram (EKG). On Study Day 2, subjects will report to the clinic after an overnight fast. Female subjects will take a urine pregnancy test. A muscle biopsy will be performed to take a small sample from one thigh. A lipid infusion will be performed for 5 hours (60 ml/hr), with blood samples taken at 8 intervals during the infusion. At the end of the 5 hour period, a second muscle biopsy will be taken from the other thigh. The fat infusion will stop, subjects will be given lunch and allowed to leave the clinic.

Conditions

Interventions

TypeNameDescription
OTHERLipid infusion and muscle biopsiesSubjects will undergo a baseline muscle biopsy, a lipid infusion for 5 hours (60 ml/hr), and a muscle biopsy after the lipid infusion.

Timeline

Start date
2012-09-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2012-11-09
Last updated
2014-05-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01724515. Inclusion in this directory is not an endorsement.